Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. ProMIS Neurosciences, Inc.
  6. News
  7. All News
    PMN   CA74346M1095

PROMIS NEUROSCIENCES, INC.

(PMN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about PROMIS NEUROSCIENCES, INC.
06/09PROMIS NEUROSCIENCESá : congratulates Biogen on FDA accelerated approval of aduc..
AQ
06/08PROMIS NEUROSCIENCESá : congratulates Biogen on FDA accelerated approval of aduc..
PU
06/07PROMIS NEUROSCIENCESá : up 30% on FDA Approval of Biogen's Aducanumab
MT
06/03PROMIS NEUROSCIENCESá : Files preliminary short form base shelf prospectus
PU
05/27PROMIS NEUROSCIENCESá : appoints renowned scientist, Dr. David Wishart as Chief ..
PU
05/25UPDATE : ProMIS Neurosciences Up 8.1% As Says initiated Commercialization of COV..
MT
05/25PROMIS NEUROSCIENCESá : Says initiated Commercialization of COVID-19 Serology As..
MT
05/25PROMIS NEUROSCIENCES BRIEF : Says initiated Commercialization of COVID-19 Serolo..
MT
05/25PROMIS NEUROSCIENCESá : initiates commercialization of COVID-19 serology assay
AQ
05/24PROMIS NEUROSCIENCESá : re-initiates path to IND for PMN310 with producer cell l..
AQ
05/21PROMIS NEUROSCIENCESá : re-initiates path to IND for PMN310 with producer cell l..
AQ
05/14PROMIS NEUROSCIENCESá : Announces First Quarter 2021 Results
AQ
05/12ProMIS Neurosciences appoints renowned neuroscientist, Dr. Rudolph Tanzi, as ..
GL
03/31PROMIS NEUROSCIENCESá : Announces Fiscal Year 2020 Results
PU
03/23PROMIS NEUROSCIENCESá : Completes US$7M Financing with Distinguished Group of Bo..
AQ
03/22PROMIS NEUROSCIENCESá : Completes US$7-Million Convertible Debenture Placement; ..
MT
03/22PROMIS NEUROSCIENCESá : IIROC Trade Resumption - PMN
AQ
03/22PROMIS NEUROSCIENCESá : IIROC Trading Halt - PMN
AQ
03/22ProMIS Neurosciences Completes US$7M (CDN$8.75M) Financing with Distinguished..
GL
02/03PROMIS NEUROSCIENCESá : Offers Perspectives on Recent Progress in the Alzheimer'..
AQ
02/02PROMIS NEUROSCIENCESá : Edging Up After Offering Perspectives on Recent Progress..
MT
02/02PROMIS NEUROSCIENCESá : Offers Perspectives on Recent Progress in the Alzheimer'..
PU
01/12PROMIS NEUROSCIENCESá : Details Strategic Priorities for 2021
MT
01/12ProMIS Neurosciences Announces Strategic Priorities for 2021
GL
2020PROMIS NEUROSCIENCESá : Year in review, looking forward to 2021
PU
2020PROMIS NEUROSCIENCESá : Completes offering of special warrants
AQ
2020PROMIS NEUROSCIENCESá : Completes Offering of Special Warrants
AQ
2020ProMIS Neurosciences Completes Offering of Special Warrants
GL
2020PROMIS NEUROSCIENCESá : Completes offering of special warrants
PU
2020PROMIS NEUROSCIENCESá : Announces Third Quarter 2020 Results
PU
2020PROMIS NEUROSCIENCESá : Announces Third Quarter 2020 Results
AQ
2020PROMIS NEUROSCIENCESá : Announces Third Quarter 2020 Results
AQ
2020ProMIS Neurosciences Announces Third Quarter 2020 Results
GL
2020PROMIS NEUROSCIENCESá : Falls to Near 52-Week Low After FDA Committee Concludes ..
MT
2020PROMIS NEUROSCIENCESá : offers comments on recent FDA Advisory Committee meeting..
PU
2020PROMIS NEUROSCIENCESá : offers comments on recent FDA Advisory Committee meeting..
AQ
2020PROMIS NEUROSCIENCESá : offers comments on recent FDA Advisory Committee meeting..
AQ
2020ProMIS Neurosciences offers comments on recent FDA Advisory Committee meeting..
GL
2020PROMIS NEUROSCIENCESá : Closes first tranche of private placement
PU
2020PROMIS NEUROSCIENCESá : Closes First Tranche of Private Placement
AQ
2020ProMIS Neurosciences Closes First Tranche of Private Placement
GL
2020PROMIS NEUROSCIENCESá : Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Research ..
AQ
2020PROMIS NEUROSCIENCESá : adds Dr. David Wishart to its Scientific Advisory Board
AQ
2020PROMIS NEUROSCIENCESá : rsquo; Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Re..
AQ
2020PROMIS NEUROSCIENCESá : rsquo; Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Re..
AQ
2020ProMIS Neurosciences' Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Research..
GL
2020PROMIS NEUROSCIENCESá : adds Dr. David Wishart to its Scientific Advisory Board
PU
2020PROMIS NEUROSCIENCESá : adds Dr. David Wishart to its Scientific Advisory Board
AQ
2020PROMIS NEUROSCIENCESá : adds Dr. David Wishart to its Scientific Advisory Board
AQ
2020ProMIS Neurosciences adds Dr. David Wishart to its Scientific Advisory Board
GL
2020PROMIS NEUROSCIENCESá : Announces up to $3 million private placement offering of..
AQ
2020PROMIS NEUROSCIENCESá : Announces up to $3 million private placement offering of..
PU
2020PROMIS NEUROSCIENCESá : Announces Up to $3 Million Private Placement Offering of..
AQ
2020ProMIS Neurosciences Announces Up to $3 Million Private Placement Offering of..
GL
2020PROMIS NEUROSCIENCES' PERSPECTIVE ON : is approval likely?
PU
2020PROMIS NEUROSCIENCESá : Offers its Perspective on the Likelihood of Regulatory A..
AQ
2020PROMIS NEUROSCIENCESá : Offers its Perspective on the Likelihood of Regulatory A..
AQ
2020ProMIS Neurosciences Offers its Perspective on the Likelihood of Regulatory A..
GL
2020PROMIS NEUROSCIENCESá : Neil Cashman to Speak at Protein Misfolding Drug Discove..
AQ
2020PROMIS NEUROSCIENCESá : rsquo; Neil Cashman to Speak at Protein Misfolding Drug ..
AQ
2020PROMIS NEUROSCIENCESá : rsquo; Neil Cashman to Speak at Protein Misfolding Drug ..
AQ
2020ProMIS Neurosciences' Neil Cashman to Speak at Protein Misfolding Drug Disco..
GL
2020PROMIS NEUROSCIENCESá : to develop multivalent vaccine for Alzheimer's disease
AQ
2020PROMIS NEUROSCIENCESá : to develop multivalent vaccine for Alzheimer's disease
PU
2020PROMIS NEUROSCIENCESá : to develop multivalent vaccine for Alzheimer's disease
AQ
2020PROMIS NEUROSCIENCESá : to develop multivalent vaccine for Alzheimer's disease
AQ
2020ProMIS Neurosciences to develop multivalent vaccine for Alzheimer's disease
GL
2020PROMIS NEUROSCIENCESá : to Participate in H.C. Wainwright & Co. 22nd Annual Inve..
AQ
2020PROMIS NEUROSCIENCESá : to Participate in H.C. Wainwright & Co. 22nd Annual Inve..
AQ
2020ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 22nd Annual Inve..
GL
2020ProMIS Neurosciences Announces Second Quarter 2020 Results
GL
2020PROMIS NEUROSCIENCESá : CEO memorandum to ProMIS shareholders, August 11, 2020
PU
2020ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders
GL
2020PROMIS NEUROSCIENCESá : and BC Neuroimmunology announce revenue-sharing joint ve..
AQ
2020ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint ve..
GL
1  2  3  4Next
Upcoming event on PROMIS NEUROSCIENCES, INC.
06/30/21